Epilepsy trials recruiting in Washington

All Epilepsy trials nationally

Cities in Washington

Recruiting trials in Washington

• A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
  NCT06660394 · Phase: Phase 3 · Ages: 2 Years to 65 Years · Sex: All (male and female) · Washington: Tacoma
• A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
  NCT04462770 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female) · Washington: Seattle
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
  NCT05667142 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Washington: Seattle
• ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
  NCT07531745 · Phase: Phase 1, Phase 2 · Ages: 2 Years to 12 Years · Sex: All (male and female) · Washington: Seattle
• North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
  NCT01694940 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Washington: Seattle
• Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
  NCT05104983 · Phase: Phase 2 · Ages: 1 Day to 6 Months · Sex: All (male and female) · Washington: Seattle
• Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
  NCT05135091 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Washington: Seattle